Switzerland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017

Switzerland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017

Summary

”Switzerland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Switzerland Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within four market categories – Central Venous Catheters, Infusion Systems, Inhalation Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct’s team of industry experts.

Scope

- Market size and company share data for Drug Delivery Devices market categories – Central Venous Catheters, Infusion Systems, Inhalation Systems, Metered Dose Inhaler Devices and Needle Free Injections.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within four market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the four market categories.
- Global corporate-level profiles of key companies operating within the Switzerland Drug Delivery Devicesmarket.
- Key players covered include GlaxoSmithKline plc, Boehringer Ingelheim GmbH, AstraZeneca PLC, Sunovion, Baxter International Inc., Teleflex Incorporated, B. Braun Melsungen AG and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Switzerland Drug Delivery Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 What is This Report About? 9
3 Drug Delivery Devices In Switzerland 10
3.1 Drug Delivery Devices, Switzerland, Overall Revenue ($m), 2003-2017 10
3.2 Drug Delivery Devices, Switzerland, Category Volume (Units), 2003-2017 16
3.3 Drug Delivery Devices, Switzerland, Company Share (2009-2010) 21
4 Central Venous Catheters In Switzerland 23
4.1 Central Venous Catheters Overall Revenue (2003-2017) 23
4.2 Central Venous Catheters Overall Volume (2003-2017) 27
4.3 Central Venous Catheters Average Price (2003-2017) 30
4.4 Central Venous Catheters Distribution Share (2009-2010) 31
4.5 Central Venous Catheters, Switzerland, Company Share (2009-2010) 32
5 Infusion Systems In Switzerland 34
5.1 Infusion Systems Overall Revenue (2003-2017) 34
5.1.1 Syringe Pumps Revenue (2003-2010) 38
5.1.2 Ambulatory Infusion Pumps Revenue (2003-2010) 40
5.2 Infusion Systems Overall Volume (2003-2017) 43
5.2.1 Syringe Pumps Volume (2003-2010) 47
5.2.2 Ambulatory Infusion Pumps Volume (2003-2010) 50
5.3 Infusion Systems Average Price (2003-2017) 54
5.4 Infusion Systems Distribution Share (2009-2010) 55
5.5 Infusion Systems, Switzerland, Company Share (2009-2010) 56
6 Metered Dose Inhaler Devices In Switzerland 58
6.1 Metered Dose Inhaler Devices Overall Revenue (2003-2017) 58
6.2 Metered Dose Inhaler Devices Overall Volume (2003-2017) 60
6.3 Metered Dose Inhaler Devices Average Price (2003-2017) 62
6.4 Metered Dose Inhaler Devices Distribution Share (2009-2010) 63
6.5 Metered Dose Inhaler Devices, Switzerland, Company Share (2009-2010) 64
7 Needle Free Injections In Switzerland 65
7.1 Needle Free Injections Overall Revenue (2003-2017) 65
7.2 Needle Free Injections Overall Volume (2003-2017) 67
7.3 Needle Free Injections Average Price (2003-2017) 69
7.4 Needle Free Injections Distribution Share (2009-2010) 70
7.5 Needle Free Injections, Switzerland, Company Share (2009-2010) 71
8 Overview of Key Companies in Switzerland Drug Delivery Devices Market 72
8.1 GlaxoSmithKline plc 72
8.1.1 Company Overview 72
8.2 AstraZeneca PLC 72
8.2.1 Company Overview 72
8.3 Teleflex Incorporated 73
8.3.1 Company Overview 73
8.4 Baxter International Inc. 73
8.4.1 Company Overview 73
8.5 B. Braun Melsungen AG 73
8.5.1 Company Overview 73
8.6 CareFusion Corporation 74
8.6.1 Company Overview 74
8.7 Hospira, Inc. 74
8.7.1 Company Overview 74
8.8 Medtronic, Inc. 75
8.8.1 Company Overview 75
8.9 Terumo Corporation 75
8.9.1 Company Overview 75
8.10 Fresenius Kabi AG 75
8.10.1 Company Overview 75
8.11 Smiths Medical 76
8.11.1 Company Overview 76
8.12 Edwards Lifesciences Corporation 76
8.12.1 Company Overview 76
8.13 3M Health Care 76
8.13.1 Company Overview 76
8.14 Consort Medical plc 77
8.14.1 Company Overview 77
8.15 Becton, Dickinson and Company 77
8.15.1 Company Overview 77
8.16 Codman & Shurtleff, Inc. 77
8.16.1 Company Overview 77
8.17 Cook Medical Incorporated 78
8.17.1 Company Overview 78
8.18 INJEX - Equidyne Systems 78
8.18.1 Company Overview 78
8.19 Antares Pharma, Inc. 78
8.19.1 Company Overview 78
8.20 Bioject Medical Technologies Inc. 79
8.20.1 Company Overview 79
9 Appendix 80
9.1 Global Markets Direct Research Methodology 80
9.2 Definitions of Markets Covered in the Report 81
9.2.1 Drug Delivery Devices 81
9.3 Secondary Research 83
9.4 Primary Research 84
9.5 Models 84
9.6 Forecasts 85
9.7 Expert Panel Validation 85
9.8 Currency Conversion 85
9.9 Contact Us 86
9.10 Disclaimer 86